Factors critical for successful vaccination against classical swine fever in endemic areas

Veterinary Microbiology

Volumn 119, Issue 1, 2007, Pages 1-9

  Suradhat, S ^a   Damrongwatanapokin, S ^b   Thanawongnuwech, R ^a  

^a CHULALONGKORN UNIVERSITY   (Thailand)

^b NATIONAL INSTITUTE OF ANIMAL HEALTH   (Thailand)

Author keywords

Classical swine fever; Immunity; Modified live vaccine; Vaccination

Indexed keywords

LIVE VACCINE; SUBUNIT VACCINE; VIRUS VACCINE;

ANTIBODY RESPONSE; ANTIBODY TITER; CELLULAR IMMUNITY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DRUG EFFICACY; ENDEMIC DISEASE; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PESTIVIRUS; REVIEW; SWINE DISEASE; T LYMPHOCYTE SUBPOPULATION; VACCINATION; VIRUS REPLICATION;

ANIMALS; CLASSICAL SWINE FEVER; CLASSICAL SWINE FEVER VIRUS; SWINE; VACCINATION; VIRAL VACCINES;

CLASSICAL SWINE FEVER VIRUS; SUIDAE; SUS SCROFA;

EID: 33845288283     PISSN: 03781135     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetmic.2006.10.003     Document Type: Review

References (50)

1. Armengol E., Wiesmuller K.H., Wienhold D., Buttner M., Pfaff E., Jung G., and Saalmuller A. Identification of T-cell epitopes in the structural and non-structural proteins of classical swine fever virus. J. Gen. Virol. 83 (2002) 551-560
2. Coggins L. Study of hog cholera colostral antibody and its effect on active hog cholera immunisation. Am. J. Vet. Res. 25 (1964) 613-616
3. Damrongwatanapokin S., Patchimasiri T., Pinyochon W., and Parchariyanon S. Efficacy of classical swine fever DLD vaccine against classical swine fever virus Chiangmai/98 isolate. J. Thai. Vet. Med. Assoc. 53 (2002) 5-14
4. Damrongwatanapokin S., Pinyochon W., Parchariyanon S., Patchimasiri T., Molee L., Udomphant S., and Damrongwatanapokin T. Efficacy of classical swine fever E2 subunit vaccine in vaccinated maternal-derived antibody positive pigs. Proceedings of the 19th IPVS congress, vol. 2. Copenhagen, Denmark (2006) 119
5. De Bruin M.G.M., Samson J.N., Voermans J.J.M., van Rooij E.M.A., De Visser Y.E., and Bianchi A.T.J. Effects of a porcine reproductive and respiratory syndrome virus infection on the development of the immune response against pseudorabies virus. Vet. Immunol. Immunopathol. 76 (2000) 125-135
6. de Smit A.J., Bouma A., de Kluijver E.P., Terpstra C., and Moormann R.J. Duration of the protection of an E2 subunit marker vaccine against classical swine fever after a single vaccination. Vet. Microbiol. 78 (2001) 307-317
7. Dewulf J., Laevens H., Koenen F., Mintiens K., and de Kruif A. An E2 sub-unit marker vaccine does not prevent horizontal or vertical transmission of classical swine fever virus. Vaccine 20 (2002) 86-91
8. Dewulf J., Koenen F., Ribbens S., Haegeman A., Laevens H., and De Kruif A. Evaluation of the epidemiological importance of classical swine fever infected. E2 sub-unit marker vaccinated animals with RT-nPCR positive blood samples. J. Vet. Med. B. Infect. Dis. Vet. Public Health 52 (2005) 367-371
9. Ganges L., Barrera M., Nunez J.I., Blanco I., Frias M.T., Rodriguez F., and Sobrino F. A DNA vaccine expressing the E2 protein of classical swine fever virus elicits T cell responses that can prime for rapid antibody production and confer total protection upon viral challenge. Vaccine 23 (2005) 3741-3752
10. Janeway Jr. C.A., Travers P., Walport M., and Capra J.D. Host Defense against Infection, Immunobiology: The Immune System in Health and Disease (1999), Elsevier Science Ltd., London pp. 363-415
11. Kaden V., Lange E., Fischer U., and Strebelow G. Oral immunization of wild boar against classical swine fever: evaluation of the first field study in Germany. Vet. Microbiol. 73 (2000) 239-252
12. Launais M., Aynaud J.M., and Corthier G. Hog cholera virus: active immunization of piglets with the Thiverval strain in the presence and absence of colostral passive immunity. Vet. Microbiol. 3 (1978) 31-43
13. Li H., and Yang H. Infection of porcine reproductive and respiratory syndrome virus suppresses the antibody response to classical swine fever virus vaccination. Vet. Microbiol. 95 (2003) 295-301
14. Mateu de Antonio E., Husmann R.J., Hansen R., Lunney J.K., Strom D., Martin S., and Zuckermann F.A. Quantitative detection of porcine interferon-gamma in response to mitogen, superantigen and recall viral antigen. Vet. Immunol. Immunopathol. 61 (1998) 265-277
15. Meng X.J. Heterogeneity of porcine reproductive and respiratory syndrome virus: implications for current vaccine efficiency and future vaccine development. Vet. Microbiol. 74 (2000) 309-329
16. Moennig V. Introduction to classical swine fever virus, disease and control policy. Vet. Microbiol. 73 (2000) 93-102
17. Parchariyanon S., Tantaswasdi U., Pinyochon W., and Methiyapun P. Immunity against swine fever vaccine. II. Immunity against swine fever vaccine in piglets and protection level of maternal immunity in piglets before vaccination. J. Thai. Vet. Med. Assoc. 45 (1994) 37-45
18. Parchariyanon S., Damrongwatanapokin S., and Pinyochon W. Status of classical swine fever disease. NIAH Newslett. 8 (1999) 1-3 (in Thai)
19. Parchariyanon S., Inui K., Damrongwatanapokin S., Pinyochon W., Lowings P., and Paton D.J. Sequence analysis of E2 glycoprotein genes of classical swine fever viruses: identification of a novel genogroup in Thailand. Dtsch. Tierarztl. Wschr. 107 (2000) 213-252
20. Parchariyanon S., Damrongwatanapokin S., Pinyochon W., Inui K., Blacksell S., and Sawada T. Diversity of classical swine fever virus in Thailand: antigenic and vaccine efficiency studies. J. Thai. Vet. Med. Assoc. 52 (2001) 9-19
21. Paton D.J., McGoldrick A., Greiser-Wilke I., Parchariyanon S., Song J.-Y., Liou P.P., Stadejek T., Lowings J.P., Bjorklund H., and Belak S. Genetic typing of classical swine fever virus. Vet. Microbiol. 73 (2000) 137-157
22. Pauly T., Elbers K., Konig M., Lengsfeld T., Saalmuller A., and Thiel H.-J. Classical swine fever virus-specific cytotoxic T lymphocytes and identification of a T cell epitope. J. Gen. Virol. 76 (1995) 3039-3049
23. Piriou L., Chevallier S., Hutet E., Charley B., Le Potire M.-F., and Albina E. Humoral and cell-mediated immune responses of d/d histocompatible pigs against classical swine fever (CSF) virus. Vet. Res. 34 (2003) 389-404
24. Povey R.C., and Carman P.S. Technical basis of vaccination. In: Pastoret P.-P., Blancou J., Vannier P., and Verschueren C. (Eds). Veterinary Vaccinology (1997), Elsevier Science B.V., Amsterdam 519-580
25. Precausta P., Kato F., and Brun A. Swine fever. Immunisation of piglets. Comp. Immunol. Microbiol. Infect. Dis. 6 (1983) 281-289
26. Rau H., Revets H., Cornelis P., Titzmann A., Ruggli N., McCullough K., and Summerfield A. Efficacy and functionality of lipoprotein OprI from Pseudomonas aeruginosa as adjuvant for a subunit vaccine against classical swine fever. Vaccine 24 (2006) 4757-4768
27. Remond M., Plateau E., and Cruciere C. In vitro study of the cellular response of pigs vaccinated against classical swine fever. Zbl. Vet. Med. B. 28 (1981) 743-748
28. Rodriguez-Carreno M.P., Lopez Fuertes L., Ezquerra R.A., Alonso F., and Dominguez J. Phenotypic characterization of porcine IFN-g-producing lymphocytes by flow cytometry. J. Immunol. Meth. 259 (2002) 171-179
29. Rümenapf T., Stark R., Meyers G., and Thiel H.-J. Structural proteins of hog cholera virus expressed by vaccinia virus: further characterization and induction of protective immunity. J. Virol. 65 (1991) 589-597
30. Saalmuller A., Werner T., and Fachinger V. T-helper cells from naive to committed. Vet. Immunol. Immunopathol. 87 (2002) 137-145
31. Summerfield A., Knotig S.M., and McCullough K.C. Lymphocyte apoptosis during classical swine fever: implication of activation-induced cell death. J. Virol. 72 (1998) 1853-1861
32. Suradhat S., and Damrongwatanapokin S. Factors that influenced an effectiveness of classical swine fever vaccine: a case study. Thai. J. Vet. Med. 32 Suppl (2002) 163-172 (in Thai with Eng abstract)
33. Suradhat S., and Damrongwatanapokin S. The influence of maternal immunity on the efficacy of a classical swine fever vaccine against classical swine fever virus, genogroup 2.2, infection. Vet. Microbiol. 92 (2003) 187-194
34. Suradhat S., and Thanawongnuwech R. Upregulation of interleukin-10 gene expression in the leukocytes of pigs infected with porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 84 (2003) 2755-2760
35. Suradhat S., Intrakamhaeng M., and Damrongwatanapokin S. The correlation of virus-specific interferon-gamma production and protection against classical swine fever virus infection. Vet. Immunol. Immunopathol. 83 (2001) 177-189
36. Suradhat S., Thanawongnuwech R., and Poovorawan Y. Upregulation of IL-10 gene expression in porcine peripheral blood mononuclear cells by porcine reproductive and respiratory syndrome virus. J. Gen. Virol. 84 (2003) 453-459
37. Suradhat S., Sada W., Buranapraditkun S., and Damrongwatanapokin S. The kinetics of cytokine production and CD25 expression by porcine lymphocyte subpopulations following exposure to classical swine fever virus (CSFV). Vet. Immunol. Immunopathol. 106 (2005) 197-208
38. Suradhat S., Keddangsakonwut S., Sada W., Buranapraditkun S., Wongsawang S., and Thanawongnuwech R. Negative impact of porcine reproductive and respiratory syndrome virus infection on the efficacy of classical swine fever vaccine. Vaccine 24 (2006) 2634-2642
39. Šuša M., Konig M., Saalmuller A., Reddehase M.J., and Thiel H.-J. Pathogenesis of classical swine fever: B-lymphocyte deficiency caused by hog cholera virus. J. Virol. 66 (1992) 1171-1175
40. Suvintrakorn K., Hanveeraphon A., and Pariyakanok V. Efficacy of lapinized swine fever vaccine in piglets born from immune sows. J. Thai. Vet. Med. Assoc. 23 (1993) 93-103
41. Terpstra C., and Wensvoort G. The protective value of vaccine-induced neutralising antibody titres in swine fever. Vet. Microbiol. 16 (1988) 123-128
42. Terpstra C., Woortmeyer R., and Barteling S.J. Development and properties of a cell culture produced vaccine for hog cholera based on the Chinese strain. Dtsch. Tierarztl. Wochenschr. 97 (1990) 77-79
43. Thacker E.L., Thacker B.J., Young T.F., and Halbur P.G. Effect of vaccination on the potentiation of porcine reproductive and respiratory syndrome virus (PRRSV)-induced pneumonia by Mycoplasma hyopneumoniae. Vaccine 18 (2000) 1244-1252
44. Thanawongnuwech R., Amonsin A., Tasanakit A., and Damrongwatanapokin S. Genetics and geographical variation of porcine reproductive and respiratory syndrome virus (PRRSV) in Thailand. Vet. Microbiol. 101 (2004) 9-21
45. Uttenthal A., Le Potier M.F., Romero L., De Mia G.M., and Floegel-Niesmann G. Classical swine fever (CSF) marker vaccine. Trial I. Challenge studies in weaner pigs. Vet. Microbiol. 83 (2001) 85-106
46. Van Oirschot J.T. Classical swine fever (Hog cholera). In: Straw B.E., D'Allaire S., Mengeling W.L., and Taylor D.J. (Eds). Disease of Swine (1999), Iowa State University Press, Ames 159-172
47. Van Oirschot J.T. Vaccinology of classical swine fever: from lab to field. Vet. Microbiol. 96 (2003) 367-384
48. Zuckermann F.A. Extrathymic CD4/CD8 double positive T cells. Vet. Immunol. Immunopathol. 72 (1999) 55-66
49. Zuckermann F.A., Husmann R.J., Schwartz R., Brandt J., Mateu de Antonio E., and Martin S. Interleukin-12 enhances the virus-specific interferon gamma response of pigs to an inactivated pseudorabies virus vaccine. Vet. Immunol. Immunopathol. 63 (1998) 57-67
50. Zuckermann F.A., Martin S., Husmann R.J., and Brandt J. Use of interleukin-12 to enhance the cellular immune response of swine to an activated herpesvirus vaccine. Adv. Vet. Med. 41 (1999) 447-461